Target intelligence / Profile preview

Golgin A2 pseudogene 9 (GOLGA2P9)

Target
GOLGA2P9
Molecular classification
Other (Pseudogene)
01

Overview

GOLGA2 pseudogene 9 (GOLGA2P9) is a pseudogene, meaning it is a non-functional genomic DNA sequence that resembles the functional GOLGA2 gene but lacks the capacity to encode a functional protein. It is not known to be involved in biological functions, disease processes, or therapeutic mechanisms. There is no evidence that GOLGA2P9 acts as a therapeutic target, biomarker, or drug-interacting protein. The protein-coding GOLGA2 gene (not the pseudogene) encodes a structural Golgi matrix protein involved in vesicle tethering, Golgi apparatus architecture, and certain neurological and muscular disorders[1][4]; however, the pseudogene GOLGA2P9 itself does not have these roles. Clarification: - GOLGA2P9 is not a protein, receptor, enzyme, transporter, or any kind of therapeutic target. - If the intention was to refer to protein-coding GOLGA2 (Golgin A2/GM130), refer instead to "Golgin A2 (GOLGA2)" and not this pseudogene[1][4]. - is_incorrect is true because pseudogenes (especially uncharacterized ones) are not valid or recognized therapeutic targets; the entry may be a result of gene annotation artifacts or misunderstandings of gene nomenclature conventions. If you require information about the functional gene GOLGA2 (Golgin A2/GM130), please clarify your request.

Other names
GOLGA2 pseudogene 9GOLGA2P9golgin A2 pseudogene 9

Beyond the preview

Go deeper on Golgin A2 pseudogene 9 (GOLGA2P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgin A2 pseudogene 9 (GOLGA2P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call